249 related articles for article (PubMed ID: 1923482)
1. [The role of antibodies in Graves' ophthalmopathy].
Molnár I; Balázs C
Orv Hetil; 1991 Sep; 132(38):2097-100. PubMed ID: 1923482
[TBL] [Abstract][Full Text] [Related]
2. Comparative study on IgG and IgA antibodies against human thyroid and eye-muscle antigens in Graves' ophthalmopathy.
Molnár I; Balázs C
Acta Med Hung; 1991; 48(1-2):13-21. PubMed ID: 1813853
[TBL] [Abstract][Full Text] [Related]
3. The relationship between anti-human eye muscle antibodies and thyroid function, anti-TSH receptor antibodies and eye symptoms in Graves' ophthalmopathy.
Molnár I; Balázs C
Wien Klin Wochenschr; 1992; 104(24):744-7. PubMed ID: 1363165
[TBL] [Abstract][Full Text] [Related]
4. Extraocular muscle antibodies and the occurrence of ophthalmopathy in Graves' disease.
de Bellis A; Perrino S; Coronella C; Sansone D; Ruocco G; Tirelli G; Di Martino S; Conte M; Bellastella G; Wall JR; Bellastella A; Bizzarro A
Clin Endocrinol (Oxf); 2004 Jun; 60(6):694-8. PubMed ID: 15163332
[TBL] [Abstract][Full Text] [Related]
5. Cloning and characterization of the novel thyroid and eye muscle shared protein G2s: autoantibodies against G2s are closely associated with ophthalmopathy in patients with Graves' hyperthyroidism.
Gunji K; De Bellis A; Li AW; Yamada M; Kubota S; Ackrell B; Wengrowicz S; Bellastella A; Bizzarro A; Sinisi A; Wall JR
J Clin Endocrinol Metab; 2000 Apr; 85(4):1641-7. PubMed ID: 10770210
[TBL] [Abstract][Full Text] [Related]
6. Cellular and humoral autoimmune responses against human eye muscle membrane antigen in Graves' disease.
Molnár I; Németi K; Bokk A; Stenszky V; Balázs C; Farid NR
Acta Med Hung; 1990; 47(1-2):43-51. PubMed ID: 2280995
[TBL] [Abstract][Full Text] [Related]
7. Reevaluation of the prevalences of serum autoantibodies reactive with "64-kd eye muscle proteins" in patients with thyroid-associated ophthalmopathy.
Kubota S; Gunji K; Stolarski C; Kennerdell JS; Wall J
Thyroid; 1998 Feb; 8(2):175-9. PubMed ID: 9510127
[TBL] [Abstract][Full Text] [Related]
8. [Muscle antigens recognized with autoantibodies in patients with Graves' ophthalmopathy].
Adler G
Endokrynol Pol; 1992; 43(1 Suppl):1-61. PubMed ID: 1345558
[TBL] [Abstract][Full Text] [Related]
9. Prevalence and significance of antibodies reactive with eye muscle membrane antigens in sera from patients with Graves' ophthalmopathy and other thyroid and nonthyroid diseases.
Wu YJ; Clarke EM; Shepherd P
Thyroid; 1998 Feb; 8(2):167-74. PubMed ID: 9510126
[TBL] [Abstract][Full Text] [Related]
10. Immunologically mediated cytotoxicity against human eye muscle cells in Graves' ophthalmopathy.
Wang PW; Hiromatsu Y; Laryea E; Wosu L; How J; Wall JR
J Clin Endocrinol Metab; 1986 Aug; 63(2):316-22. PubMed ID: 3755139
[TBL] [Abstract][Full Text] [Related]
11. Affinity purification of orbital membrane antigens for the study of the pathogenesis of Graves' ophthalmopathy.
Salvi M; Bingoye F; Chung F; Wall JR
J Clin Endocrinol Metab; 1988 May; 66(5):939-45. PubMed ID: 3360902
[TBL] [Abstract][Full Text] [Related]
12. Antithyroglobulin monoclonal and autoantibodies cross-react with an orbital connective tissue membrane antigen: a possible mechanism for the association of ophthalmopathy with autoimmune thyroid disorders.
Kuroki T; Ruf J; Whelan L; Miller A; Wall JR
Clin Exp Immunol; 1985 Nov; 62(2):361-70. PubMed ID: 3841305
[TBL] [Abstract][Full Text] [Related]
13. Graves' ophthalmopathy: what is the evidence for extraocular muscle specific autoantibodies.
van der Gaag R; Vernimmen R; Fiebelkorn N; van Dierendonck MC; Kijlstra A
Int Ophthalmol; 1990 Jan; 14(1):25-30. PubMed ID: 2182563
[TBL] [Abstract][Full Text] [Related]
14. Antibodies to porcine eye muscle in patients with Graves' ophthalmopathy: identification of serum immunoglobulins directed against unique determinants by immunoblotting and enzyme-linked immunosorbent assay.
Ahmann A; Baker JR; Weetman AP; Wartofsky L; Nutman TB; Burman KD
J Clin Endocrinol Metab; 1987 Mar; 64(3):454-60. PubMed ID: 2434519
[TBL] [Abstract][Full Text] [Related]
15. Study of serum antibodies against three eye muscle antigens and the connective tissue antigen collagen XIII in patients with Graves' disease with and without ophthalmopathy: correlation with clinical features.
Gopinath B; Musselman R; Adams CL; Tani J; Beard N; Wall JR
Thyroid; 2006 Oct; 16(10):967-74. PubMed ID: 17042681
[TBL] [Abstract][Full Text] [Related]
16. Measurement of autoantibodies against human eye muscle plasma membranes in Graves' ophthalmopathy.
Faryna M; Nauman J; Gardas A
Br Med J (Clin Res Ed); 1985 Jan; 290(6463):191-2. PubMed ID: 3917747
[TBL] [Abstract][Full Text] [Related]
17. Detection of the novel autoantibody (anti-UACA antibody) in patients with Graves' disease.
Ohkura T; Taniguchi S; Yamada K; Nishio N; Okamura T; Yoshida A; Kamijou K; Fukata S; Kuma K; Inoue Y; Hisatome I; Senju S; Nishimura Y; Shigemasa C
Biochem Biophys Res Commun; 2004 Aug; 321(2):432-40. PubMed ID: 15358194
[TBL] [Abstract][Full Text] [Related]
18. Analysis of the IgG autoantibody repertoire in endocrine ophthalmopathy using the MegaBlot technique.
Grus FH; Augustin AJ
Curr Eye Res; 1998 Jun; 17(6):636-41. PubMed ID: 9663853
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of a new autoantibody against a human eye muscle soluble antigen, detected by immunofluorescence.
Mengistu M; Laryea E; Miller A; Wall JR
Clin Exp Immunol; 1986 Jul; 65(1):19-27. PubMed ID: 3539423
[TBL] [Abstract][Full Text] [Related]
20. Soluble interleukin-2 receptor in sera of patients with Graves' disease.
Balázs C; Farid NR
Acta Med Hung; 1991; 48(1-2):3-11. PubMed ID: 1813855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
